GetTopicDetailResponse(id=28d2e173746, topicName=白細胞介素4/13單抗, introduction=白細胞介素4/13單抗, content=null, image=null, comments=2, allHits=724, url=https://h5.medsci.cn/topic?id=71737, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=93109, tagList=[TagDto(tagId=93109, tagName=白細胞介素4/13單抗)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1800124, encodeId=f0571800124e4, content=<a href='/topic/show?id=28d2e173746' target=_blank style='color:#2F92EE;'>#白細胞介素4/13單抗#</a>, objectTitle=白細胞介素4/13單抗Dupixent銷售額持續(xù)增長，但未能扭轉(zhuǎn)賽諾菲因流感疫苗和糖尿病藥物導(dǎo)致的整體銷售額下降, objectType=article, longId=182339, objectId=d449182339d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d449182339d2, replyNumber=0, likeNumber=87, createdTime=2020-09-02, rootId=0, userName=ms9608593228839890, userId=6ea92500119, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d449182339d2, moduleTitle=白細胞介素4/13單抗Dupixent銷售額持續(xù)增長，但未能扭轉(zhuǎn)賽諾菲因流感疫苗和糖尿病藥物導(dǎo)致的整體銷售額下降, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=d449182339d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1800123, encodeId=f0c1180012317, content=<a href='/topic/show?id=28d2e173746' target=_blank style='color:#2F92EE;'>#白細胞介素4/13單抗#</a>, objectTitle=賽諾菲白細胞介素4/13單抗Dupixent在嚴重特應(yīng)性皮炎兒童患者的III期試驗成功, objectType=article, longId=177128, objectId=d21f1e7128a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d21f1e7128a2, replyNumber=0, likeNumber=96, createdTime=2019-09-30, rootId=0, userName=ms9608593228839890, userId=6ea92500119, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d21f1e7128a2, moduleTitle=賽諾菲白細胞介素4/13單抗Dupixent在嚴重特應(yīng)性皮炎兒童患者的III期試驗成功, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=d21f1e7128a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
